To date, several studies have addressed the signaling pathways induced by PD-L1 in cancer cells, connecting mTOR/AKT activation with increased PD-L1 activities in cancer cells, including in breast tumor cells [11,12,13,14]. Here, AKT1 is linked to cancer.